News
Exploristics joins the Avicenna Alliance
The Avicenna Alliance is proud to announce the newest addition to its list of members: Exploristics. Based in Belfast, Exploristics provide world-class analytics through specialised software products and services to pharmaceutical and life sciences sectors.
Avicenna present at the European Research & Innovation Days
The European Research and Innovation days was a three-day event in Brussels, during which researchers, academics, businesses, decision-makers and parliament representatives from Europe and beyond took part in a co-design process to shape the priorities and strategic plan for the first four years of Horizon Europe, due to start in 2021.
SAVE THE DATE! Ansys-FDA-Avicenna event in Washington on 11 October 2019
Innovation through healthcare simulationFor those of you who will be in Washington mid-October, ANSYS, in cooperation with the FDA and the Avicenna Alliance, is organizing a roundtable discussion titled "Transforming Computational Modeling from A Valuable Scientific Tool to A Valuable Regulatory Tool: Myth or Reality?"
Avicenna answers online consultation to shape Horizon Europe
On 23 July the Avicenna Alliance has submitted its opinion to on the strategic priorities of Horizon Europe, the EU’s next framework programme for research and innovation (R&I). The Commission had indeed launched an online consultation addressed to individuals and organisations with an interest in the future EU R&I priorities.
Prestigious FDA award allocated to group that developed the V&V 40 standard
The Avicenna Alliance is proud to announce that some of its working group members have received the FDA Crosscutting Group Honor Award on 2 August 2019.
Dassault Systèmes signs Research Agreement with the FDA
Dassault Systèmes and the U.S. Food and Drug Administration have concluded a five-year extension of their collaboration on the 3DEXPERIENCE platform in order to develop a new digital tool to enable more efficient regulatory review of cardiovascular and medical devices.
